KraneShares MSCI All China Health Care Index ETF (KURE) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the KraneShares MSCI All China Health Care Index ETF stock forecast from 0 analysts, the average analyst target price for KraneShares MSCI All China Health Care Index ETF is not available over the next 12 months. KraneShares MSCI All China Health Care Index ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of KraneShares MSCI All China Health Care Index ETF is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, KraneShares MSCI All China Health Care Index ETF’s stock price was USD 14.17. KraneShares MSCI All China Health Care Index ETF’s stock price has changed by +2.27% over the past week, -3.61% over the past month and -32.67% over the last year.
No recent analyst target price found for KraneShares MSCI All China Health Care Index ETF
No recent average analyst rating found for KraneShares MSCI All China Health Care Index ETF
Company Overview KraneShares MSCI All China Health Care Index ETF
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified. Read Less
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market...Read More
N/A
N/A
N/A
N/A
USD
USA
31/01/2018
MSCI China All Shares HC 10/40 NR USD
N/A
0.65 %
Adjusted Closing Price for KraneShares MSCI All China Health Care Index ETF (KURE)
Loading...
Unadjusted Closing Price for KraneShares MSCI All China Health Care Index ETF (KURE)
Loading...
Share Trading Volume for KraneShares MSCI All China Health Care Index ETF Shares
Loading...
Compare Performance of KraneShares MSCI All China Health Care Index ETF Shares
Frequently Asked Questions About KraneShares MSCI All China Health Care Index ETF (KURE) Stock
Stock Target Advisor's fundamental analysis for KraneShares MSCI All China Health Care Index ETF's stock is Very Bearish.
KURE stock's dividend yield is 0.71%.
Our analysis grades KURE stock's dividend yield at F. This means that KURE stock's dividend yield is above 16% of the stocks in the China Region sector in the NYE exchange.
Based on this KURE may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on KURE's stock to indicate what its average analyst target is.
KURE stock's Price/Earning ratio is 22.00.
Our analysis grades KURE stock's Price / Earning ratio at F. This means that KURE stock's Price/Earning ratio is above 79% of the stocks in the China Region sector in the NYE exchange.
Based on this KURE may be a overvalued for its sector.
The last closing price of KURE's stock was USD 14.17.
The most recent market capitalization for KURE is USD 0.05B.
Unfortunately we do not have enough analyst data on KURE's stock to indicate whether its price will go up or not.
Following are ETFs with the highest allocation to KraneShares MSCI All China Health Care Index ETF's stock :
Sorry, we do not have any data on the number of employees for KraneShares MSCI All China Health Care Index ETF.
Sorry we do not have any infomation available on KraneShares MSCI All China Health Care Index ETF's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for KURE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
